Vol 1, No 3 (October 30, 2012): Translational Cancer Research (Particle Beam Therapy I)

Editorial

Charged particle beam therapy: a new dawn for cancer treatment
Huan Giap, Eric Y Chuang
Translational Cancer Research  
2012;
1
(3)
:125-126
.

Review Articles

Historical perspective and evolution of charged particle beam therapy
Huan Giap, Bosco Giap
Translational Cancer Research  
2012;
1
(3)
:127-136
.
Particle therapy for central nervous system tumors in pediatric and adult patients
Jeffrey Q Dinh, Anita Mahajan, Matthew B Palmer, David R Grosshans
Translational Cancer Research  
2012;
1
(3)
:137-149
.
Proton therapy for gastrointestinal cancers
Ted C. Ling, Joseph I. Kang, Jerry D. Slater, Gary Y. Yang
Translational Cancer Research  
2012;
1
(3)
:150-158
.
Stereotactic radiosurgery with charged-particle beams: technique and clinical experience
Richard P. Levy, Reinhard W. M. Schulte
Translational Cancer Research  
2012;
1
(3)
:159-172
.
Proton beam radiation therapy of prostate cancer - history, results, and future directions
Carl J Jr Rossi
Translational Cancer Research  
2012;
1
(3)
:173-183
.
New developments in treatment planning and verification of particle beam therapy
Reinhard W. Schulte, Andrew J. Wroe
Translational Cancer Research  
2012;
1
(3)
:184-195
.
Improving the precision and performance of proton pencil beam scanning
Sairos Safai, Christian Bula, David Meer, Eros Pedroni
Translational Cancer Research  
2012;
1
(3)
:196-206
.
Proton therapy dose calculations on GPU: advances and challenges
Xun Jia, Todd Pawlicki, Kevin T. Murphy, Arno J. Mundt
Translational Cancer Research  
2012;
1
(3)
:207-216
.
Toward robust proton therapy planning and delivery
Zuofeng Li
Translational Cancer Research  
2012;
1
(3)
:217-226
.
Emerging evidence for the role of an endorectal balloon in prostate radiation therapy
Stefan Both, Curtiland Deville, Viet Bui, Ken Kang-Hsin Wang, Neha Vapiwala
Translational Cancer Research  
2012;
1
(3)
:227-235
.

Disclosure:

The focused issue “Particle Beam Therapy I” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding. Huan Giap and Eric Y Chuang served as the unpaid Guest Editors for the focused issue.